Recombinant Human Glyoxalase I Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 4959-GL
Key Product Details
Product Specifications
Source
Ala2-Met184, with an N-terminal Met and 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >100 nmol/min/µg, as measured under the described conditions.
Formulation, Preparation and Storage
4959-GL
Formulation | Lyophilized from a 0.2 μm filtered solution in Tris-HCl and DTT. |
Reconstitution |
Reconstitute at 0.5 mg/mL in sterile, deionized water.
|
Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Glyoxalase I
Glyoxalase I (also lactoylglutathione lyase, methylglyoxalase, and glx I) is a 21 kDa member of the Glyoxalase I family. The enzyme is an isomerase that catalyzes the formation of S-D-lactoylglutathione from the hemimercaptal adduct that forms spontaneously between methylglyoxal and reduced GSH (1-4). The monomeric subunit for human Glyoxalase I is 184 amino acids (aa) in length. In the mature protein, the methionine at the N-terminus is removed. Human Glyoxalase I exists in three separable isoforms as homo-and hetero-dimers of two allelic subunit variants, which differ in charge (1). The isoforms are formed when residue 19 is changed from cysteine to tyrosine and residue 111 is changed from glutamine to alanine. Each subunit binds one Zn2+ atom (1, 3-4). The protein is made up of multiple beta strands and alpha helical regions. Human Glyoxalase I shares 91% and 90% aa sequence identity with rat and mouse Glyoxalase I, respectively. The enzyme is ubiquitously expressed and is also present in many tumor cell lines, in which its concentration is often upregulated (1). The biological role of the enzyme remains unclear, but the glyoxalase system detoxifies the precursors of advanced glycation end products, which take part in the pathogenesis of vascular, diabetic, and uremic complications (5).
References
- Ridderstrom, M. & B. Mannervik (1996) Biochem. J. 314:463.
- Marmstal, E. & B. Mannervik (1981) FEBS Lett. 131:301.
- Kim, N-S. et al. (1993) J. Biol. Chem. 268:11217.
- Ranganathan, S. et al. (1993) J. Biol. Chem. 268:5661.
- Kalousova, M. et al. (2007) Ann. N. Y. Acad. Sci. 1126:268.
Alternate Names
Gene Symbol
UniProt
Additional Glyoxalase I Products
Product Documents for Recombinant Human Glyoxalase I Protein, CF
Product Specific Notices for Recombinant Human Glyoxalase I Protein, CF
For research use only